Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network

Journal of Substance Abuse Treatment

Volumn 30, Issue 4, 2006, Pages 315-321

  Brown Jr , Lawrence S ^a,b   Kritz, Steven Allan ^a   Goldsmith, R Jeffrey ^c   Bini, Edmund J ^d   Rotrosen, John ^d   Baker, Sherryl ^e   Robinson, Jim ^e   McAuliffe, Patrick ^f  

^a Addiction Research and Treatment Corporation   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^f Nathan Kline Institute ^*  (United States)

Author keywords

Community treatment program; Hepatitis C virus infection; HIV AIDS; National Drug Abuse Treatment Clinical Trials Network; Sexually transmitted infections

Indexed keywords

ILLICIT DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADMINISTRATIVE PERSONNEL; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DEPENDENCE TREATMENT; GOVERNMENT; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL STAFF; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CLINICAL TRIALS; DELIVERY OF HEALTH CARE; HEPATITIS C; HIV INFECTIONS; HUMANS; PROGRAM DEVELOPMENT; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33747456336     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.02.006     Document Type: Article

References (30)

1. Bachmann L.H., Lewis I., Allen R., Schwebke J.R., Leviton L.C., Siegal H.A., et al. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. American Journal of Public Health 90 (2000) 1615-1618
2. Battjes R.J., Pickens R.W., and Brown L.S. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: An update. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 (1995) 90-96
3. Belongia E.A., Danila R.N., Angamuthu V., Hickman C.D., DeBoer J.M., MacDonald K.L., et al. A population-based study of sexually transmitted disease incidence and risk factors in human immunodeficiency virus-infected people. Sexually Transmitted Diseases 24 (1997) 251-256
4. Booth R.E., Watters J.K., and Chitwood D.D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health 83 (1993) 1144-1147
5. Broers B., Junet C., Bourquin M., Deglon J.J., Perrin L., and Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 12 (1998) 2059-2066
6. Brown L.S., Chu A., Nemoto T., Ajuluchukwu D., and Primm B.J. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City: Demographic, behavioral, and clinical features. New York State Journal of Medicine 89 (1989) 506-510
7. Chiasson M.A., Stoneburner R.L., Hilderbrandt D.S., Ewing W.E., Telzak E.E., and Jaffe H.A. Heterosexual transmission of HIV-1 associated with the use of smokeable freebase cocaine (crack). AIDS 5 (1991) 1121-1126
8. Cooper J.R. Methadone treatment and acquired immunodeficiency syndrome. Journal of the American Medical Association 262 (1989) 1664-1668
9. Fortenberry J.D., Brizendine E.J., Katz B.P., Woods K.K., Blythe M.J., and Orr D.P. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sexually Transmitted Diseases 26 (1999) 26-32
10. Francis H. Substance abuse and HIV infection. Topics in HIV Medicine 11 (2003) 20-24
11. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes 18 Suppl 1 (1998) s11-s19
12. Hartel D.M., and Schoenbaum E.E. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, NYC. Public Health Report 113 (1998) 107-115
13. Hintze J. NCSS and PASS (2001), Number Cruncher Statistical Systems, Kaysville (UT)
14. Hubbard R.L., Marsden M.E., Cavanaugh E., Rachal J.V., and Ginsburg H.M. Role of drug abuse treatment in limiting the spread of AIDS. Reviews of Infectious Diseases 10 (1988) 377-384
15. Lally M.A., Alvarez S., Macnevin R., Cenedella C., Dispigno M., Harwell J.I., et al. Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment. Sexually Transmitted Diseases 29 (2002) 752-755
16. Lally M.A., MacNevin R., Sergie Z., Hitt R., Dispigno M., Cenedella C., et al. A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center. AIDS Patient Care STDS 19 (2005) 298-305
17. In: Lamb S., Greenlick M.R., and McCarty D. (Eds). Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment (1998), National Academy Press, Washington (DC)
18. Lorvich J., Kral H.H., Seal K., Gee L., and Edlin B.R. Prevalence and duration of Hepatitis C among injection drug users in San Francisco, CA. American Journal of Public Health 91 (2001) 46-47
19. Metzger D.S., Navaline H., and Woody G.E. Drug abuse treatment as AIDS prevention. Public Health Reports 113 (1998) 97-106
20. Plitt S.S., Garfein R.S., Gaydos C.A., Strathdee S.A., Sherman S.G., and Taha T.E. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sexually Transmitted Diseases 32 (2005) 446-453
21. Poulin C., Alary M., Bernier F., Ringuet J., and Joly J.R. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV infection among drug users attending an STD/HIV prevention and needle-exchange program in Quebec City, Canada. Sexually Transmitted Diseases 26 (1999) 410-420
22. Rotrosen J., Leshner A., Tai B., Greenlick M., Pencer E., Trachtenberg R., et al. The National Drug Abuse Treatment Clinical Trials Network-Challenges and opportunities. NIDA Research Monograph Series 182 (2002) 12-17
23. Smith M.U., Goudeau R.E., Katner H.P., and Farmer J.T. Human immunodeficiency virus infection: Knowledge of the disease and opinions toward related issues and policies among health care workers in a low-incidence non urban hospital. Southern Medical Journal 86 (1993) 537-544
24. Sorensen J.L., and Copeland A.L. Drug abuse treatment as an HIV prevention strategy: A review. Drug Alcohol Dependence 59 (2000) 17-31
25. Strauss S.M., Falkin G.P., Vassilev Z., Des Jarlais D.C., and Astone J. A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment 22 (2002) 55-62
26. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2003 National Survey on Drug Use and Health: National findings (2004), Office of Applied Studies, Rockville, MD (NSDUH Series H-25, DHHS Publication No. SMA 04-3964)
27. Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Applied Studies. National Survey of Substance Abuse Treatment Services (N-SSATS): (2003). Data on substance abuse treatment facilities (2004), Office of Applied Studies, Rockville, MD (DASIS Series S-24, DHHS Publication No. SMA 04-3966)
28. Sylvestre D.L. Treating hepatitis C in methadone maintenance patients: An interim analysis. Drug Alcohol Dependence 67 (2002) 117-123
29. Thomas D.L., Vlahov D., Solomon L., Cohn S., Taylor E., Garfein R., et al. Correlates of Hepatitis C virus infection among injection drug users. Medicine 74 (1995) 212-220
30. Zylberberg H., and Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clinical Infectious Diseases 23 (1996) 1117-1125 (Review)